A Phase I Trial Of The Humanized Anti-GD2 Antibody In Children And Adolescents With Neuroblastoma, Osteosarcoma, Ewing Sarcoma and Melanoma
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Neuroblastoma
Related studies linked through entity extraction aliases.
Expanded Access Protocol for [123I]mIBG for Patients With Known or Suspected Neuroblastoma
- Status
- APPROVED_FOR_MARKETING
- Phase
- N/A
The Effectiveness of the Neutropenic Diet in Pediatric Oncology Patients
- Status
- COMPLETED
- Phase
- NA
Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy
- Status
- COMPLETED
- Phase
- PHASE3
A Phase I/II Study Of Immunization With Lymphotactin And Interleukin 2 Gene Modified Neuroblastoma Tumor Cells
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Haploidentical Natural Killer (NK) Cells in Patients With Relapsed or Refractory Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE2
Long Term Follow Up Of Patients Who Have Received Gene Therapy Or Gene Marked Products
- Status
- COMPLETED
- Phase
- N/A
Autologous Transplant Followed by Allogeneic Transplant for High Risk Neuroblastoma
- Status
- TERMINATED
- Phase
- PHASE1
N2007-01: Ultratrace™ Iobenguane I 131 in Patients With Relapsed/Refractory High-Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2
T Cells in Predicting Acute Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- N/A
N2004-03: Intravenous Fenretinide in Treating Young Patients With Recurrent or Resistant Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Study of Irinotecan and Bortezomib in Children With Recurrent/Refractory Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Early Enteral Tube Feedings in Children Receiving Chemo for AML/MDS & High Risk Solid Tumors
- Status
- WITHDRAWN
- Phase
- NA
Prevalence+Significance of Paraneoplastic Autoantibodies in Many Cancers
- Status
- COMPLETED
- Phase
- N/A
Deferasirox in Treating Patients With Iron Overload After Undergoing a Donor Stem Cell Transplant
- Status
- TERMINATED
- Phase
- PHASE2
Study of Nifurtimox to Treat Refractory or Relapsed Neuroblastoma or Medulloblastoma
- Status
- COMPLETED
- Phase
- PHASE2
I-123-MIBG for Imaging of Neuroblastoma and Pheochromocytoma
- Status
- COMPLETED
- Phase
- N/A
Molecular Characterization of Neuroblastic Tumor: Correlation With Clinical Outcome
- Status
- RECRUITING
- Phase
- N/A
Tumor Detection Using Iodine-131-Labeled Monoclonal Antibody 8H9
- Status
- TERMINATED
- Phase
- NA
Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma
- Status
- COMPLETED
- Phase
- PHASE2